rs1975514

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.2969-31A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.36 in 1,596,810 control chromosomes in the GnomAD database, including 104,856 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.34 ( 8872 hom., cov: 32)
Exomes 𝑓: 0.36 ( 95984 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.279

Publications

12 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 1 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 13-110176544-T-C is Benign according to our data. Variant chr13-110176544-T-C is described in ClinVar as Benign. ClinVar VariationId is 1293324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.366 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.2969-31A>G intron_variant Intron 35 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.2969-31A>G intron_variant Intron 35 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.340
AC:
51665
AN:
151916
Hom.:
8859
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.277
Gnomad AMI
AF:
0.567
Gnomad AMR
AF:
0.362
Gnomad ASJ
AF:
0.340
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.363
Gnomad FIN
AF:
0.349
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.370
Gnomad OTH
AF:
0.354
GnomAD2 exomes
AF:
0.356
AC:
89231
AN:
250612
AF XY:
0.357
show subpopulations
Gnomad AFR exome
AF:
0.279
Gnomad AMR exome
AF:
0.396
Gnomad ASJ exome
AF:
0.316
Gnomad EAS exome
AF:
0.302
Gnomad FIN exome
AF:
0.351
Gnomad NFE exome
AF:
0.365
Gnomad OTH exome
AF:
0.352
GnomAD4 exome
AF:
0.362
AC:
523171
AN:
1444776
Hom.:
95984
Cov.:
28
AF XY:
0.362
AC XY:
260885
AN XY:
719874
show subpopulations
African (AFR)
AF:
0.269
AC:
8923
AN:
33166
American (AMR)
AF:
0.393
AC:
17549
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.318
AC:
8283
AN:
26010
East Asian (EAS)
AF:
0.268
AC:
10614
AN:
39632
South Asian (SAS)
AF:
0.365
AC:
31334
AN:
85896
European-Finnish (FIN)
AF:
0.353
AC:
18828
AN:
53370
Middle Eastern (MID)
AF:
0.264
AC:
1516
AN:
5736
European-Non Finnish (NFE)
AF:
0.369
AC:
404915
AN:
1096474
Other (OTH)
AF:
0.355
AC:
21209
AN:
59822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
18587
37175
55762
74350
92937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12714
25428
38142
50856
63570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.340
AC:
51718
AN:
152034
Hom.:
8872
Cov.:
32
AF XY:
0.340
AC XY:
25290
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.277
AC:
11498
AN:
41460
American (AMR)
AF:
0.362
AC:
5539
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.340
AC:
1182
AN:
3472
East Asian (EAS)
AF:
0.302
AC:
1554
AN:
5150
South Asian (SAS)
AF:
0.364
AC:
1753
AN:
4820
European-Finnish (FIN)
AF:
0.349
AC:
3693
AN:
10576
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.370
AC:
25140
AN:
67964
Other (OTH)
AF:
0.359
AC:
756
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1768
3536
5305
7073
8841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.281
Hom.:
1572
Bravo
AF:
0.338
Asia WGS
AF:
0.362
AC:
1256
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.61
DANN
Benign
0.43
PhyloP100
0.28
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1975514; hg19: chr13-110828891; COSMIC: COSV65430826; API